Cronos Appoints Anna Shlimak as Chief Financial Officer
Cronos Group (NASDAQ: CRON) has appointed Anna Shlimak as Chief Financial Officer, effective March 19, 2025. Shlimak, previously serving as Chief Strategy Officer, succeeds James Holm who will remain with the company through April 18, 2025 to ensure a smooth transition.
Shlimak has been a key member of Cronos' leadership team for seven years, where she has led strategic initiatives in cost optimization, revenue growth, and corporate brand building. CEO Mike Gorenstein expressed confidence in Shlimak's ability to drive financial strategy and growth, citing her deep understanding of the business and track record in driving financial performance.
James Holm, departing after two and a half years, will pursue other opportunities after contributing to improving the company's finance functions and building a robust finance team.
Cronos Group (NASDAQ: CRON) ha nominato Anna Shlimak come Chief Financial Officer, con effetto dal 19 marzo 2025. Shlimak, che in precedenza ha ricoperto il ruolo di Chief Strategy Officer, succede a James Holm, il quale rimarrà in azienda fino al 18 aprile 2025 per garantire una transizione fluida.
Shlimak è stata un membro chiave del team di leadership di Cronos per sette anni, dove ha guidato iniziative strategiche nell'ottimizzazione dei costi, nella crescita dei ricavi e nello sviluppo del marchio aziendale. Il CEO Mike Gorenstein ha espresso fiducia nella capacità di Shlimak di guidare la strategia finanziaria e la crescita, citando la sua profonda comprensione del business e il suo storico nel migliorare le performance finanziarie.
James Holm, che lascia dopo due anni e mezzo, cercherà altre opportunità dopo aver contribuito a migliorare le funzioni finanziarie dell'azienda e a costruire un robusto team finanziario.
Cronos Group (NASDAQ: CRON) ha nombrado a Anna Shlimak como Directora Financiera, con efecto a partir del 19 de marzo de 2025. Shlimak, quien anteriormente se desempeñaba como Directora de Estrategia, sucede a James Holm, quien permanecerá en la empresa hasta el 18 de abril de 2025 para asegurar una transición fluida.
Shlimak ha sido un miembro clave del equipo de liderazgo de Cronos durante siete años, donde ha liderado iniciativas estratégicas en optimización de costos, crecimiento de ingresos y construcción de marca corporativa. El CEO Mike Gorenstein expresó confianza en la capacidad de Shlimak para impulsar la estrategia financiera y el crecimiento, citando su profundo entendimiento del negocio y su historial en mejorar el rendimiento financiero.
James Holm, que se va después de dos años y medio, buscará otras oportunidades tras contribuir a mejorar las funciones financieras de la empresa y a construir un equipo financiero sólido.
크로노스 그룹 (NASDAQ: CRON)이 안나 슐리막을 최고재무책임자(CFO)로 임명했습니다. 임기는 2025년 3월 19일부터 시작됩니다. 슐리막은 이전에 최고전략책임자(CSO)로 재직했으며, 제임스 홀름의 뒤를 이어 취임하게 됩니다. 홀름은 2025년 4월 18일까지 회사에 남아 원활한 전환을 보장할 것입니다.
슐리막은 크로노스의 리더십 팀의 핵심 멤버로 7년 동안 활동하며 비용 최적화, 수익 성장 및 기업 브랜드 구축과 같은 전략적 이니셔티브를 이끌어 왔습니다. CEO 마이크 고렌스타인은 슐리막이 재무 전략과 성장을 이끌어낼 수 있는 능력에 대한 신뢰를 표명하며, 그녀의 비즈니스에 대한 깊은 이해와 재무 성과 향상에 대한 경력을 언급했습니다.
제임스 홀름은 2년 반 만에 회사를 떠나며, 회사의 재무 기능 개선과 강력한 재무 팀 구축에 기여한 후 다른 기회를 모색할 것입니다.
Cronos Group (NASDAQ: CRON) a nommé Anna Shlimak au poste de Directrice Financière (CFO), à compter du 19 mars 2025. Shlimak, qui occupait auparavant le poste de Directrice de la Stratégie, succède à James Holm, qui restera dans l'entreprise jusqu'au 18 avril 2025 pour assurer une transition en douceur.
Shlimak a été un membre clé de l'équipe de direction de Cronos pendant sept ans, où elle a dirigé des initiatives stratégiques en matière d'optimisation des coûts, de croissance des revenus et de construction de la marque. Le PDG Mike Gorenstein a exprimé sa confiance dans la capacité de Shlimak à piloter la stratégie financière et la croissance, citant sa compréhension approfondie de l'entreprise et son parcours dans l'amélioration de la performance financière.
James Holm, qui part après deux ans et demi, cherchera d'autres opportunités après avoir contribué à améliorer les fonctions financières de l'entreprise et à constituer une équipe financière solide.
Cronos Group (NASDAQ: CRON) hat Anna Shlimak zur Finanzchefin (CFO) ernannt, die am 19. März 2025 in Kraft tritt. Shlimak, die zuvor als Chief Strategy Officer tätig war, tritt die Nachfolge von James Holm an, der bis zum 18. April 2025 im Unternehmen bleibt, um einen reibungslosen Übergang zu gewährleisten.
Shlimak ist seit sieben Jahren ein wichtiges Mitglied des Führungsteams von Cronos und hat strategische Initiativen zur Kostenoptimierung, Umsatzsteigerung und Markenbildung geleitet. CEO Mike Gorenstein äußerte Vertrauen in Shlimaks Fähigkeit, die Finanzstrategie und das Wachstum voranzutreiben, und verwies auf ihr tiefes Verständnis des Geschäfts sowie ihre Erfolge bei der Verbesserung der finanziellen Leistung.
James Holm, der nach zweieinhalb Jahren geht, wird nach seiner Mitwirkung an der Verbesserung der Finanzfunktionen des Unternehmens und dem Aufbau eines soliden Finanzteams andere Möglichkeiten suchen.
- Seamless leadership transition with month-long handover period
- New CFO has 7 years of company experience and proven track record
- Internal promotion indicates strong succession planning
- Departure of current CFO after only 2.5 years in position
TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos’ Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition.
Ms. Shlimak has been an integral part of Cronos’ leadership team for the last seven years, playing a key role in shaping the Company’s strategy, operational efficiencies, and engagement with the financial and investment community. During her tenure, she has led many strategic initiatives including cost optimization, revenue growth, and building Cronos’ corporate brand, which have positioned the Company for long-term success.
“I am incredibly pleased Anna Shlimak is stepping into the Chief Financial Officer role,” said Mike Gorenstein, President and Chief Executive Officer, Cronos. “Anna has been an essential part of our senior leadership team. With a deep understanding of our business and a proven track record of driving financial performance, operational efficiency and strategic growth, Anna is the ideal leader to help drive our financial strategy and next phase of growth.
Mr. Gorenstein continued, “I want to sincerely thank James for his contributions to Cronos. He played an important role in improving our finance functions and has worked to build a robust Finance team. His commitment to Cronos has been essential and I thank James for everything he’s contributed to the Company and wish him all the best in his future endeavors.”
Mr. Holm said, “I'm incredibly proud of what we've accomplished over the past two and a half years and look forward to watching the Cronos team continue to deliver strong results. Under Anna’s leadership, I’m confident the Company will continue to grow and lead the cannabis industry on a global scale.”
Ms. Shlimak said, “I am honored to step into the role of CFO and continue working alongside our talented teams. Cronos is committed to building exceptional cannabis brands and products that enhance experiences, and I am excited to lead our financial and strategic growth as we continue to expand and drive performance. As we enter the next phase of growth, I look forward to driving long-term value for our shareholders, employees, and consumers.”
About Anna Shlimak
Anna recently served as the Company’s Chief Strategy Officer and was responsible for managing and directing the organization’s corporate strategy, investor relations, communications, government affairs, and information systems departments. Prior to joining Cronos, Anna was the Head of Investor Relations at Quest Partners LLC, a research-driven alternative investment firm. Anna was responsible for business development, investor reporting, marketing, and communication initiatives for the fund. Before that, Anna held a range of roles at the New York Stock Exchange in both the New York and London offices. She received a Master of Business Administration from Columbia Business School and holds a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania.
About Cronos Group Inc.
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.
Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about transition plans with respect to the Company’s Chief Financial Officer role; the Company’s growth, industry leadership, success and financial strategy; long-term value for the Company’s shareholders, employees and consumers; and the Company’s intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.
Media Relations Contact:
Emily Whalen
Communications
Tel: (416) 504-0004
media.relations@thecronosgroup.com
Investor Relations Contact:
Tel: (416) 504-0004
investor.relations@thecronosgroup.com
FAQ
When will Anna Shlimak take over as CFO of Cronos (CRON)?
How long has Anna Shlimak been with Cronos (CRON) before becoming CFO?
When is James Holm leaving Cronos (CRON)?
What were Anna Shlimak's key achievements at Cronos (CRON) before becoming CFO?
